🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific action to tackle household expense issues" in the forthcoming financial statement.

Speaking to the BBC, she emphasized that curbing inflation is a shared responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Potential Energy Cost Measures

Reports indicate the administration could intervene to bring down energy bills, for example by reducing the present 5% level of VAT applied on energy supplies.

Another approach is to cut some of the policy costs currently included in household expenses.

Fiscal Constraints and Expert Expectations

The administration will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The consensus from the majority of analysts is that Reeves will have to announce tax increases or expenditure reductions in order to fulfill her voluntary fiscal targets.

Previously on the same day, calculations indicated there was a £22 billion gap for the Treasury chief to fill, which is at the lower end of forecasts.

"It is a shared job between the central bank and the government to bear down further on some of the sources of price increases," the Chancellor told the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and Global Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent information from the OBR had not changed her vow to election pledges not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain world" with growing international and trade tensions for the fiscal tax moves, probably to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Commenting on apprehensions about the United Kingdom's trade ties with China she said: "Our security interests always come first."

Recent declaration by Chinese authorities to strengthen export controls on rare earths and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an extra 100% tariff on imports from the Asian country, increasing the prospect of an full-scale commercial conflict between the two global powers.

The American finance chief called the Chinese move "commercial pressure" and "a global supply chain control attempt."

Asked about accepting the American proposal to participate in its conflict with China, Reeves said she was "extremely troubled" by Chinese actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the international commerce and causes additional challenges."

"In my view there are fields where we need to challenge China, but there are also valuable prospects to export to Chinese markets, including financial services and other areas of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are more independent."

Health Service Drug Costs and Investment

The Chancellor also recognized that the cost the National Health Service pays for drugs could go up as a consequence of current talks with the Trump administration and its drugs companies, in return for reduced taxes and funding.

A number of the world's largest drug companies have said recently that they are either pausing or abandoning projects in the UK, with several attributing the low prices they are getting.

Last month, the government science advisor said the price the health service pays for drugs would must rise to stop firms and drug research funding departing from the United Kingdom.

Reeves told the BBC: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been available in the United Kingdom in the extent that they are in other EU nations."

"Our aim is to ensure that individuals getting care from the National Health Service are can obtain the best critical treatments in the world. And so we are examining all of that, and... seeking to secure increased funding into the UK."